Re: Exempt Dist.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Exempt Dist.

in response to

Exempt Dist.

RVXoldtimer

posted on Apr 15, 2021 06:32AM

Another promissory note. Well, as long as they are unsecured I suppose it's all good.

I believe the previous one was for ~$2 Mil CAN.

Koo

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply